| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |